ACO Clinical Updates: Advances in Diabetes Pharmacotherapy
Claiming Credit
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to watch the video, complete the posttest, evaluation and claim your credit on the following page.
Please note that the video starts at 3 minutes.
Target Audience
Primary care clinicians
Learning Objectives
- Outline the latest approaches to treating diabetes.
- Describe which patients benefit from GLP-1 RAs and what the major benefits and risk factors are.
- Describe which patients benefit from SGLT-2 inhibitors and what the major benefits and risk factors are.
- Describe which patients benefit the most from which diabetes medication class regardless of A1c.
Devin W Steenkamp, MBChB - Faculty
Christine Pace, MD - Course Director
Debra Harris - Program Manager
Naomi Moeller - CME Program Manager
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation
Claiming Credit
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to watch the video, complete the posttest, evaluation and claim your credit on the following page.
Please note that the video starts at 3 minutes.